Close
Back to SHRM Stock Lookup

(SHRM) – Globe Newswire

Sep 15, 2020 01:31 PM Champignon Provides Update on Disclosure Review
Aug 27, 2020 01:39 PM Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence
Jul 24, 2020 03:00 PM Champignon Announces Filing of Business Acquisition Reports and Appointment of Director
Jul 13, 2020 08:00 AM Champignon Provides Corporate Update
Jun 22, 2020 09:14 AM Champignon Announces Regulatory Review
Jun 19, 2020 08:00 AM REPEAT - Champignon’s Dr. McIntyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals
Jun 19, 2020 03:05 AM Champignon’s Dr. Mcintyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals
Jun 15, 2020 08:00 AM REPEAT - Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out
Jun 12, 2020 04:25 PM Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out
Jun 8, 2020 08:00 AM REPEAT - Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio
Jun 8, 2020 03:05 AM Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio
May 29, 2020 08:00 AM Champignon Announces Voluntary Share Lock-Up; Retains Gold Standard Media, LLC for Financial Marketing Services
May 25, 2020 08:00 AM REPEAT - Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors
May 25, 2020 03:05 AM Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors
May 19, 2020 08:00 AM REPEAT - Champignon Sponsors Non-profit Coalition, TheraPsil - Medical Psilocybin Access Project for Palliative Cancer Patients and Health Professionals
May 18, 2020 03:05 AM Champignon Sponsors Non-profit Coalition, TheraPsil - Medical Psilocybin Access Project for Palliative Cancer Patients and Health Professionals
May 12, 2020 10:00 AM Champignon Expands to U.S., To Acquire California Based Ketamine Centre – Wellness Clinic of Orange County
May 11, 2020 08:00 AM REPEAT - Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer
May 11, 2020 03:05 AM Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer
May 6, 2020 08:00 AM REPEAT - Champignon Appoints Pat McCutcheon to Board of Directors
May 6, 2020 03:05 AM Champignon Appoints Pat McCutcheon to Board of Directors
May 4, 2020 08:00 AM Champignon Forms North American Clinical Expansion Committee
Apr 30, 2020 11:46 AM Le traitement à base de kétamine de Champignon sera distribué par une importante chaîne de pharmacie canadienne et la compagnie annonce la clôture de la transaction d'AltMed
Apr 30, 2020 03:05 AM Champignon Ketamine Treatment to be Dispensed by Major Canadian Pharmacy Chain; Closes AltMed
Apr 28, 2020 07:00 AM Champignon Selected as Headline Partner for PSYCH: The Psychedelics Symposium at Prohibition Partners LIVE
Apr 23, 2020 08:00 AM Champignon Commences U.S. Trading on the OTCQB Venture Market Under Ticker Symbol “SHRMF”
Apr 22, 2020 10:09 AM REPEAT - Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami
Apr 22, 2020 03:05 AM Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami
Apr 17, 2020 12:01 PM Champignon Receives DTC Eligibility
Apr 16, 2020 08:00 AM REPEAT - Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee
Apr 16, 2020 03:05 AM Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee
Apr 13, 2020 08:00 AM REPEAT - CHAMPIGNON TO ACQUIRE ALTMED CAPITAL CORP., CONTRIBUTING HEALTH CANADA'S ONLY APPROVED PSYCHEDELIC MEDICINE CLINIC, SOPs FOR CLINICAL EXPANSION, EXISTING IP & MULTIPLE TRIALS
Apr 9, 2020 07:17 PM CHAMPIGNON TO ACQUIRE ALTMED CAPITAL CORP., CONTRIBUTING HEALTH CANADA'S ONLY APPROVED PSYCHEDELIC MEDICINE CLINIC, SOPs FOR CLINICAL EXPANSION, EXISTING IP & MULTIPLE TRIALS
Apr 3, 2020 08:30 AM Champignon Featured in Broadcast on Mental Health Options, Medical Mushrooms
Apr 1, 2020 08:30 AM Champignon Brands Spotlighted in Publication Discussing Potential of Mushrooms in Medicine
Mar 31, 2020 08:00 AM REPEAT - CHAMPIGNON APPOINTS UNIVERSITY OF TORONTO CLINICAL ADVISOR, PHARMACOGNOSIST TO SPECIAL ADVISORY COMMITTEE
Mar 31, 2020 03:05 AM CHAMPIGNON APPOINTS UNIVERSITY OF TORONTO CLINICAL ADVISOR, PHARMACOGNOSIST TO SPECIAL ADVISORY COMMITTEE
Mar 30, 2020 08:00 AM REPEAT - CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI
Mar 27, 2020 04:05 PM CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI
Mar 25, 2020 08:00 AM REPEAT - CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA™ INVENTOR TO SPECIAL ADVISORY COMMITTEE
Mar 25, 2020 03:05 AM CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA™ INVENTOR TO SPECIAL ADVISORY COMMITTEE
Mar 20, 2020 12:00 PM CHAMPIGNON BRANDS ANNOUNCES NORMAL COURSE ISSUER BID FOR COMMON SHARES OF THE CORPORATION
Mar 19, 2020 01:00 PM CHAMPIGNON BRANDS EXPANDS ALTERNATIVE MEDICINE IP PORTFOLIO WITH KETAMINE, ADAPTOGENIC DELIVERY SYSTEMS/FORMULATIONS
Mar 16, 2020 08:00 AM REPEAT: Champignon Brands to Acquire Craft Mushroom Cultivator
Mar 13, 2020 05:00 PM Champignon Brands to Acquire Craft Mushroom Cultivator
Mar 5, 2020 08:30 AM Champignon Brands Spotlighted in Publication Discussing Mushrooms in Medicine
Mar 4, 2020 08:00 AM Champignon Brands Completes Listing; to Form Special Advisory Committee
Mar 2, 2020 07:15 PM Champignon Brands Grants Stock Options
Feb 28, 2020 05:26 PM Champignon Brands Inc. Completes Initial Public Offering

Back to SHRM Stock Lookup